Medtronic Q4 2024 Adj EPS $1.46 Beats $1.45 Estimate, Sales $8.589B Beat $8.437B Estimate
Portfolio Pulse from Benzinga Newsdesk
Medtronic reported its Q4 2024 results, with adjusted EPS of $1.46 beating the estimate of $1.45, and sales of $8.589 billion surpassing the $8.437 billion estimate.
May 23, 2024 | 10:47 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Medtronic's Q4 2024 adjusted EPS of $1.46 beat the estimate of $1.45, and sales of $8.589 billion surpassed the $8.437 billion estimate, indicating strong financial performance.
Medtronic's better-than-expected EPS and sales figures suggest strong financial health and operational efficiency, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100